Iuliia Efimova

1.0k total citations · 1 hit paper
12 papers, 834 citations indexed

About

Iuliia Efimova is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Oncology. According to data from OpenAlex, Iuliia Efimova has authored 12 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in Iuliia Efimova's work include Ferroptosis and cancer prognosis (4 papers), Immunotherapy and Immune Responses (3 papers) and Immune cells in cancer (3 papers). Iuliia Efimova is often cited by papers focused on Ferroptosis and cancer prognosis (4 papers), Immunotherapy and Immune Responses (3 papers) and Immune cells in cancer (3 papers). Iuliia Efimova collaborates with scholars based in Belgium, Russia and Italy. Iuliia Efimova's co-authors include Dmitri V. Krysko, Olga Krysko, Maria V. Vedunova, Victoria D. Turubanova, Claus Bachert, Tatiana A. Mishchenko, Elena Catanzaro, Frauke Coppieters, Louis Van der Meeren and André G. Skirtach and has published in prestigious journals such as Scientific Reports, Journal of Controlled Release and Frontiers in Immunology.

In The Last Decade

Iuliia Efimova

12 papers receiving 830 citations

Hit Papers

Vaccination with early ferroptotic cancer cells induces e... 2020 2026 2022 2024 2020 100 200 300

Peers

Iuliia Efimova
Hiroaki Wakiyama United States
Ai‐Hong Ma United States
John J. Amante United States
Yuze Hua China
Iuliia Efimova
Citations per year, relative to Iuliia Efimova Iuliia Efimova (= 1×) peers Victoria D. Turubanova

Countries citing papers authored by Iuliia Efimova

Since Specialization
Citations

This map shows the geographic impact of Iuliia Efimova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iuliia Efimova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iuliia Efimova more than expected).

Fields of papers citing papers by Iuliia Efimova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iuliia Efimova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iuliia Efimova. The network helps show where Iuliia Efimova may publish in the future.

Co-authorship network of co-authors of Iuliia Efimova

This figure shows the co-authorship network connecting the top 25 collaborators of Iuliia Efimova. A scholar is included among the top collaborators of Iuliia Efimova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iuliia Efimova. Iuliia Efimova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Efimova, Iuliia, et al.. (2024). Cytofluorometric analysis of the maturation and activation of bone marrow-derived dendritic cells to assess immunogenic cell death. Methods in cell biology. 190. 51–74. 2 indexed citations
2.
Efimova, Iuliia, Greet De Smet, Tatiana A. Mishchenko, et al.. (2024). CX3CL1 release during immunogenic apoptosis is associated with enhanced anti-tumour immunity. Frontiers in Immunology. 15. 1396349–1396349. 6 indexed citations
3.
Efimova, Iuliia, et al.. (2023). The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartments. Journal of Controlled Release. 364. 142–158. 3 indexed citations
4.
Meeren, Louis Van der, et al.. (2023). Mechanobiology of Ferroptotic Cancer Cells as a Novel “Eat‐Me” Signal: Regulating Efferocytosis through Layer‐by‐Layer Coating. Advanced Healthcare Materials. 12(28). e2301025–e2301025. 7 indexed citations
5.
Efimova, Iuliia, et al.. (2023). Ferroptosis: friend or foe in cancer immunotherapy?. OncoImmunology. 12(1). 2182992–2182992. 12 indexed citations
6.
Vedunova, Maria V., Victoria D. Turubanova, Iuliia Efimova, et al.. (2022). DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosis. Cell Death and Disease. 13(12). 1062–1062. 30 indexed citations
7.
Krysko, Dmitri V., et al.. (2022). In Vitro Veritas: From 2D Cultures to Organ-on-a-Chip Models to Study Immunogenic Cell Death in the Tumor Microenvironment. Cells. 11(22). 3705–3705. 15 indexed citations
8.
Turubanova, Victoria D., Tatiana A. Mishchenko, Irina V. Balalaeva, et al.. (2021). Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death. Scientific Reports. 11(1). 7205–7205. 47 indexed citations
9.
Efimova, Iuliia, et al.. (2021). Immunogenic ferroptosis and where to find it?. Journal for ImmunoTherapy of Cancer. 9(12). e003430–e003430. 100 indexed citations
10.
Efimova, Iuliia, Elena Catanzaro, Louis Van der Meeren, et al.. (2020). Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. Journal for ImmunoTherapy of Cancer. 8(2). e001369–e001369. 367 indexed citations breakdown →
11.
Efimova, Iuliia, et al.. (2020). A 3D Cell Death Assay to Quantitatively Determine Ferroptosis in Spheroids. Cells. 9(3). 703–703. 25 indexed citations
12.
Turubanova, Victoria D., Irina V. Balalaeva, Tatiana A. Mishchenko, et al.. (2019). Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine. Journal for ImmunoTherapy of Cancer. 7(1). 350–350. 220 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026